Team:Goettingen/Project

From 2013.igem.org

(Difference between revisions)
m (Target: c-di-AMP)
(Target: c-di-AMP)
 
(24 intermediate revisions not shown)
Line 16: Line 16:
<html>
<html>
<div id="body">
<div id="body">
-
<div class="f-box" style="height:570px">
+
<div class="f-box" style="height:676px">
<div class="d-box br">
<div class="d-box br">
</html>
</html>
===Target: c-di-AMP===
===Target: c-di-AMP===
-
<p>Since the discovery of penicillin by Alexander Fleming in 1928, antibiotics have marked a major victory of mankind in the battle against infectious diseases. However, after 90 years, the antibiotics are now losing their old time glory: Bacteria acquire resistance against antibiotics and become unbridled.</p>
+
<p>Since the discovery of penicillin by Alexander Fleming in 1928, antibiotics have marked a major victory of mankind in the battle against infectious diseases. However, after 90 years, the available antibiotics are losing their old time glory: Bacteria can rapidly acquire resistance against antibiotics and become unbridled.</p>
-
<p>We should have better control over the use of antibiotics, meanwhile, we need to develop new ones, which can sufficiently eliminate the invaders without hurting the "good" bacteria. Therefore, c-di-AMP, an important, recently discovered signaling molecule in gram-positive bacteria, has come to our sight.</p>
+
<p>We should have better control over the use of antibiotics, meanwhile, we need to develop new ones, which can sufficiently eliminate the invaders without hurting the "good" bacteria. Therefore, c-di-AMP, a recently discovered signaling molecule that is <strong>essential</strong> in many pathogenic bacteria, has come to our sight.</p>
-
<p>Our project is aimed at finding a way to fight against multi-resistant bacteria by targeting c-di-AMP. We made three different approaches, each approach was accomplished by each subteam, for detailed information, please click the icon on the right panel</p>
+
<p>Our project is aimed at finding a way to fight against multi-resistant bacteria by targeting c-di-AMP. We made three different approaches, each approach was accomplished by a subteam, for detailed information, please click the icon on the right panel.</p>
-
<p style="margin-left:20px; " class="goe-rt">first, we have built two screening systems, which could be applied in novel-drug screening. With this system, the level of c-di-AMP in the cell can be visualized and measured</p>
+
<p style="margin-left: 150px;text-indent: -125px;"><strong>Reporter Team: </strong>development of a reporter system to monitor c-di-AMP levels <i>in vivo</i></p>
-
<p style="margin-left:20px; " class="goe-dac">We also looked into the diadenylate cyclase(DAC), which can be a great novel target for new antibiotics. We have expressed the truncated DAC(the catalytical domain) from <i>Listeria monocytogenes</i> in <i>E.coli</i>, characterized and  crystallized it and finally got a STRUCTURE. </p>
+
<p style="margin-left: 150px;text-indent: -100px;"><strong>Array Team: </strong>identification of regulatory elements that bind to c-di-AMP</p>
-
<p style="margin-left:20px" class="goe-array">We searched for the genes effect by the level of c-di-AMP and we found <i>ydaO</i>.We identified the Ribo-Switch upstream <i>ydaO</i> and used it directly in our screening system.</p>
+
<p style="margin-left: 150px;text-indent: -95px;
 +
"><strong>DAC Team: </strong>characterisation of a diadenylate cyclase that produces c-di-AMP.</p>
<p>After over 3 month of work, we have finally wrapped up. To know more details about our lab work, please visit [[Team:Goettingen/NoteBook|Our Lab Book]].</p>
<p>After over 3 month of work, we have finally wrapped up. To know more details about our lab work, please visit [[Team:Goettingen/NoteBook|Our Lab Book]].</p>
-
<p>We conducted all our work on the North Campus of University Goettingen, in the Microbiology department. All work was done in our S1 level lab. We follow strickly the safety S1 instructions. To know more about safety issues, please [[Team:Goettingen/Safety|visit our safety page]].
+
<p>We conducted all experiments in a S1 level lab in the Department of General Microbiology that is located on the North Campus of the Göttingen University. We strickly stuck to the rules that have to be followed during work in a S1 lab. To know more about safety issues, please [[Team:Goettingen/Safety|visit our safety page]].
=== ===
=== ===
Line 55: Line 56:
</a>
</a>
-
<a href="/Team:Goettingen/Reporter" style="margin-left:50px;display:inline-block;text-decoration:none;">
+
<a href="/Team:Goettingen/Team/Reporter" style="margin-left:50px;display:inline-block;text-decoration:none;">
<h2  style="text-align:center">Reporter Team</h2>
<h2  style="text-align:center">Reporter Team</h2>
<img src="https://static.igem.org/mediawiki/2013/7/75/Goe-reporter.png"/>
<img src="https://static.igem.org/mediawiki/2013/7/75/Goe-reporter.png"/>

Latest revision as of 13:24, 4 October 2013





The beast and its Achilles heel:

 A novel target to fight multi-resistant pathogenic bacteria


Target: c-di-AMP

Since the discovery of penicillin by Alexander Fleming in 1928, antibiotics have marked a major victory of mankind in the battle against infectious diseases. However, after 90 years, the available antibiotics are losing their old time glory: Bacteria can rapidly acquire resistance against antibiotics and become unbridled.

We should have better control over the use of antibiotics, meanwhile, we need to develop new ones, which can sufficiently eliminate the invaders without hurting the "good" bacteria. Therefore, c-di-AMP, a recently discovered signaling molecule that is essential in many pathogenic bacteria, has come to our sight.

Our project is aimed at finding a way to fight against multi-resistant bacteria by targeting c-di-AMP. We made three different approaches, each approach was accomplished by a subteam, for detailed information, please click the icon on the right panel.

Reporter Team: development of a reporter system to monitor c-di-AMP levels in vivo

Array Team: identification of regulatory elements that bind to c-di-AMP

DAC Team: characterisation of a diadenylate cyclase that produces c-di-AMP.

After over 3 month of work, we have finally wrapped up. To know more details about our lab work, please visit Our Lab Book.

We conducted all experiments in a S1 level lab in the Department of General Microbiology that is located on the North Campus of the Göttingen University. We strickly stuck to the rules that have to be followed during work in a S1 lab. To know more about safety issues, please visit our safety page.



Retrieved from "http://2013.igem.org/Team:Goettingen/Project"